Houston Psychoanalytic Society

Online Meet-the-Author Event

Psychodynamic Psychopharmacology:

Caring for the Treatment-Resistant Patient 

Discussion with Author

David Mintz, MD

Interview by Catherine Stevenson, MD

Thursday, February 20, 2025

7:00PM – 8:30PM Central Time


Live via Zoom

This event will not be recorded


1.5 CME/CEU/CE Credits


Registration Fees

HPS Full Members: $30

HPS Student Members: $15

Non-Members: $40

Registration closes February 18, 2025


Instructional Level: Beginning-Advanced

REGISTER

This event would be of interest to a general audience of psychodynamic clinicians as well as those who prescribe medications. Though the book is generally aimed at prescribers, with a framework for how to integrate psychodynamic understandings and techniques to address dynamics driving treatment resistance, Dr. Mintz and Dr. Stevenson plan to focus their interview on the first part of the book. Those sections focus on (1) how the data challenges assumptions about mind-body dualism, (2) ways that pharmacotherapy and the prescribing act (and interprofessional relations) are suffused with dynamics, and (3) psychodynamics driving treatment resistance in patients who are prescribed medications.


The histories of psychoanalysis and biomedical psychiatry have promoted a polarization between these disciplines. Often, this has led psychoanalysts to adopt a narrowly biomedical view of psychopharmacology (while simultaneously being critical of biopsychiatry for holding a biomedically-reductionist focus). Under scrutiny, a dualistic understanding of pharmacotherapy breaks down. In many cases, psychiatric medications are even more symbolically-active than they are directly biologically-active. Psychoanalysis has much to say about symbolic aspects of pharmacotherapy and clinically-meaningful aspects of the therapeutic relationship that can be helpful to psychiatry. At the same time, polarization has promoted a general neglect of interactions of pharmacotherapy and psychoanalysis, despite the fact that a large percentage of analysands are now receiving both treatments. In this discussion, we will consider a specific model for integrating psychodynamics and pharmacotherapy, Psychodynamic Psychopharmacology, as well as broader questions of the relationship of psychoanalysis and pharmacotherapy.


LEARNING OBJECTIVES

After attending the program in its entirety, attendees will be able to:

  1. Describe several mechanisms by which psychodynamic factors shape pharmacologic treatment outcomes.
  2. Describe antagonisms and synergies between psychoanalysis and psychopharmacology.

Presenters

Author David Mintz, MD is the Director of Psychiatric Education and Associate Director of Training at the Austen Riggs Center, where he conducts psychoanalytic treatments with a complex, co-morbid population of patients who have not benefited sufficiently from first and second-line treatments. In the context of this work, he and his colleagues have developed a psychodynamically-informed approach to pharmacologic treatment-resistance. His book on the topic is Psychodynamic Psychopharmacology: Caring for the Treatment Resistant Patient, published by American Psychiatric Publishing. His other primary focus is on integrating psychodynamics into medical education. Dr. Mintz directs a psychodynamic elective at the Austen Riggs Center for medical students and residents, has spearheaded the development of a national Psychotherapy Fair for interested medical students, and directs an annual conference at Riggs on psychodynamic applications in work with complex and difficult-to-treat patients. He is the 2024 recipient of the Massachusetts Psychiatric Society Outstanding Psychiatrist Award in Education. He is a past Trustee of the American Academy of Psychodynamic Psychiatry and Psychoanalysis, recent past leader of the Psychotherapy Caucus of the American Psychiatric Association, a member of the Psychotherapy Committee of AADPRT and the Medical Student Education Committee of the American Psychoanalytic Association.


Interviewer Catherine Stevenson, MD is a Candidate's and Consulting Analyst at the Center for Psychoanalytic Studies in Houston, Texas and also a clinical faculty member of the Menninger Department of Psychiatry at Baylor College of Medicine. She is a former president of the Houston Psychoanalytic Society and has completed the Neuroscience Education Institute Master Psychopharmacologist Program with high honors. A portion of her practice is providing medication management for patients in therapy or psychoanalysis with other members of the Center and the Society. Since 2011 Dr. Stevenson has presented a workshop, "Psychopharmacology for Non-Prescribers," every few years to update the HPS community. In her academic work she explores the intersections of spirituality, art, and psychology, and has a doctorate in spirituality from the Angelicum in Rome. She is currently working on a MFA in nonfiction writing at Sewanee. In Houston she can found painting in the studio at the Glassell School or doing tai chi on the lawn of the Asia Society.


REFERENCES

King, I., & Shapiro, Y. (2022). Learning the “science of the art of prescribing”: From evidence-based algorithms to individualized medicine in psychiatric care. Journal of Psychiatric Practice®28(5), 409-420.


Mintz, D (2022). Psychodynamic psychopharmacology: Caring for the treatment-resistant patient, Washington DC.: American Psychiatric Publishing.


Mintz, D (2022). Recovery from childhood psychiatric treatment: Addressing the meaning of medications. Psychodynamic Psychiatry, 50(1), 131-148.


Mintz, D and Azer, J (2024). Integrating psychoanalysis and pharmacotherapy. In G. Gabbard, B. Litowitz, & Stern, D. (Eds.) Textbook of Psychoanalysis, 3rd Edition, Washington DC.: American Psychiatric Publishing.

Agenda

7:00 - 7:05 pm Introduction

7:05 - 8:00 pm Discussion with Dr. Mintz and Dr. Stevenson

8:00 - 8:30 pm | Presenter-led question and answer session

Disclosures

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Psychoanalytic Association and Houston Psychoanalytic Society. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.


AMA Credit Designation Statement

The American Psychoanalytic Association designates this Live Activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Statement

The APsA CE Committee has reviewed the materials for accredited continuing education and has determined that this activity is not related to the product line of ineligible companies and therefore, the activity meets the exception outlined in Standard 3: ACCME's identification, mitigation and disclosure of relevant financial relationship. This activity does not have any known commercial support. 


APA Accreditation Statement

Houston Psychoanalytic Society is approved by the American Psychological Association to sponsor continuing education for psychologists. Houston Psychoanalytic Society maintains responsibility for this program and its content.


HPS, through co-sponsorship with the Center for Psychoanalytic Studies, also offers approved CEUs for Texas state-approved social workers, licensed professional counselors, and marriage and family therapists.

1302 Waugh Dr. #276, Houston, TX 77019
(713) 429-5810
Facebook  Twitter  Linkedin